Enhancing Oral Solid Dose Solubility And Bioavailability With Amorphous Solid Dispersions (ASD)

Pharmaceutics International, Inc. (Pii) will accelerate your early development through clinical studies for challenging, complex oral solid dose formulations with state-of-the-art spray drying technology.

Solubility and bioavailability are inherent challenges in the early stages of development for oral solid dose pharmaceuticals. Struggling to overcome these hurdles can cost drug sponsors precious time and resources and ultimately place their commercialization hopes at risk, as well as, the hopes of patients depending on new therapies to treat their disease or illness.